1. Home
  2. MYNZ vs OP Comparison

MYNZ vs OP Comparison

Compare MYNZ & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • OP
  • Stock Information
  • Founded
  • MYNZ 2021
  • OP 2021
  • Country
  • MYNZ Germany
  • OP Greece
  • Employees
  • MYNZ N/A
  • OP N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • OP
  • Sector
  • MYNZ Health Care
  • OP
  • Exchange
  • MYNZ Nasdaq
  • OP Nasdaq
  • Market Cap
  • MYNZ 5.5M
  • OP 5.3M
  • IPO Year
  • MYNZ 2021
  • OP N/A
  • Fundamental
  • Price
  • MYNZ $1.37
  • OP $1.98
  • Analyst Decision
  • MYNZ Buy
  • OP
  • Analyst Count
  • MYNZ 2
  • OP 0
  • Target Price
  • MYNZ $14.00
  • OP N/A
  • AVG Volume (30 Days)
  • MYNZ 118.7K
  • OP 9.3M
  • Earning Date
  • MYNZ 07-07-2025
  • OP 08-06-2025
  • Dividend Yield
  • MYNZ N/A
  • OP N/A
  • EPS Growth
  • MYNZ N/A
  • OP N/A
  • EPS
  • MYNZ N/A
  • OP N/A
  • Revenue
  • MYNZ $893,991.00
  • OP $25,702,000.00
  • Revenue This Year
  • MYNZ $26.06
  • OP N/A
  • Revenue Next Year
  • MYNZ $4.97
  • OP N/A
  • P/E Ratio
  • MYNZ N/A
  • OP N/A
  • Revenue Growth
  • MYNZ N/A
  • OP 35.58
  • 52 Week Low
  • MYNZ $1.34
  • OP $0.63
  • 52 Week High
  • MYNZ $22.40
  • OP $3.17
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 23.25
  • OP 57.24
  • Support Level
  • MYNZ $1.34
  • OP $1.82
  • Resistance Level
  • MYNZ $1.48
  • OP $2.30
  • Average True Range (ATR)
  • MYNZ 0.13
  • OP 0.48
  • MACD
  • MYNZ -0.01
  • OP 0.08
  • Stochastic Oscillator
  • MYNZ 3.72
  • OP 49.40

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.

Share on Social Networks: